URMC » Research » Research@URMC

Featured Blog Post Image

Telomeres Might Predict Lung Cancer Recurrence

Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.

New Visualization Lab Will Help Researchers Unlock Big Data’s Secrets

The University of Rochester has provided a sneak peek of one of its newest – and perhaps coolest – research resources, one that will help scientists better understand and manipulate large and complex sets of data.

6/24/2014 | 0 comments

Best Time for Joint Replacement? Don’t Wait Too Long

An analysis of national patient data shows there’s an ideal time for having hip or knee replacement surgery – and it occurs before you can’t walk or can't take the pain anymore.

6/18/2014 | 2 comments

Nobel Laureate Visits Rochester for Genetics Day 2014

The 26th Annual Genetics Day 2014, held recently at the university campus had an extra special keynote lecture by one of the latest Nobel Laureates. Additionally, there were research talks by faculty members and posters by students and trainees.  The afternoon saw a special session of remembering longtime University faculty member and legendary geneticist Fred Sherman.

6/12/2014 | 0 comments

Study: Companions Often Silence Patient’s Voice

Companions often speak on behalf of patients during discussions of cancer treatment and prognosis, even when the patient is present and capable of speaking on his or her own behalf, according to a new study by the Wilmot Cancer Institute and UR Family Medicine.

6/11/2014 | 0 comments

Nature Gives Shout-Out to Wilmot for Immune Therapy Research

One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.

6/4/2014 | 0 comments